Search results
Results from the WOW.Com Content Network
Dacarbazine, also known as imidazole carboxamide and sold under the brand name DTIC-Dome, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma. [3] For Hodgkin's lymphoma it is often used together with vinblastine, bleomycin, and doxorubicin. [3] It is given by injection into a vein. [3]
Dan Bennett, 59, credits TIL therapy with allowing him to beat the slim odds of long-term survival of stage 4 melanoma. His daughter, Faith Bennett, 29, first noticed a suspicious mole on Bennett ...
This is a list of specialist hospitals for treatment of cancer. This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources. Cancer Hospitals Australia Peter MacCallum Cancer Centre Victorian Comprehensive Cancer Centre Bangladesh National Institute of Cancer Research and Hospital Brazil Institute of ...
The surgeries and complex treatment regimens used in cancer therapy have led the term to be used mainly to describe adjuvant cancer treatments. An example of such adjuvant therapy is the additional treatment [ 1 ] usually given after surgery where all detectable disease has been removed, but where there remains a statistical risk of relapse due ...
The Karmanos Cancer Institute has 16 treatment locations [1] and is one of 57 National Cancer Institute-designated comprehensive cancer treatment and research centers in the United States. [ 2 ] Karmanos' vision is a world free of cancer and its mission is to lead in transformative cancer care, research and education through courage, commitment ...
Induction chemotherapy is the first line treatment of cancer with a chemotherapeutic drug. This type of chemotherapy is used for curative intent. [1] [6]: 55–59 Combined modality chemotherapy is the use of drugs with other cancer treatments, such as surgery, radiation therapy, or hyperthermia therapy.
There are targeted therapies for lung cancer, colorectal cancer, head and neck cancer, breast cancer, multiple myeloma, lymphoma, prostate cancer, melanoma and other cancers. [ 1 ] [ 4 ] [ 5 ] Biomarkers are usually required to aid the selection of patients who will likely respond to a given targeted therapy.
Nivolumab is approved to treat melanoma, lung cancer, kidney cancer, bladder cancer, head and neck cancer, and Hodgkin's lymphoma. [160] A 2016 clinical trial for non-small cell lung cancer failed to meet its primary endpoint for treatment in the first-line setting, but is FDA-approved in subsequent lines of therapy.